Literature DB >> 8070584

Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin.

T Rahn1, M Ridderstråle, H Tornqvist, V Manganiello, G Fredrikson, P Belfrage, E Degerman.   

Abstract

Incubation of rat adipocytes with wortmannin, a potent and selective phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor, completely blocked the antilipolytic action of insulin (IC50 = 100 nM), the insulin-induced activation and phosphorylation of cGMP-inhibited cAMP phosphodiesterase (cGI-PDE) as well as the activation of the insulin-stimulated cGI-PDE kinase (IC50 = 10-30 nM). No direct effects of the inhibitor on the insulin-stimulated cGI-PDE kinase, the cGI-PDE and the hormone-sensitive lipase were observed. These data suggest that activation of PI 3-kinase upstream of the insulin-stimulated cGI-PDE kinase in the antilipolytic insulin signalchain has an essential role for insulin-induced cGI-PDE activation/phosphorylation and anti-lipolysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070584     DOI: 10.1016/0014-5793(94)00797-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase.

Authors:  Sameer Mohammad; Lavoisier S Ramos; Jochen Buck; Lonny R Levin; Francesco Rubino; Timothy E McGraw
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

2.  Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt.

Authors:  T Kitamura; Y Kitamura; S Kuroda; Y Hino; M Ando; K Kotani; H Konishi; H Matsuzaki; U Kikkawa; W Ogawa; M Kasuga
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 3.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

Review 4.  Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling.

Authors:  Rosalind A Coleman; Douglas G Mashek
Journal:  Chem Rev       Date:  2011-06-01       Impact factor: 60.622

Review 5.  Role of binding proteins to IRS-1 in insulin signalling.

Authors:  W Ogawa; T Matozaki; M Kasuga
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

6.  The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin.

Authors:  Lisa M DiPilato; Faiyaz Ahmad; Matthew Harms; Patrick Seale; Vincent Manganiello; Morris J Birnbaum
Journal:  Mol Cell Biol       Date:  2015-06-01       Impact factor: 4.272

Review 7.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

8.  Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes.

Authors:  I Castan; J Wijkander; V Manganiello; E Degerman
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

Review 9.  Insulin signalling mechanisms for triacylglycerol storage.

Authors:  M P Czech; M Tencerova; D J Pedersen; M Aouadi
Journal:  Diabetologia       Date:  2013-02-27       Impact factor: 10.122

10.  Phosphatidylinositol 3-kinase is an upstream regulator of the phosphodiesterase 3B pathway of leptin signalling that may not involve activation of Akt in the rat hypothalamus.

Authors:  A Sahu; K Koshinaka; M Sahu
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.